Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com Employees: 275 P: 412-586-5830

Sector:

Medical

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,265,588
Enterprise Value, $K 7,920,718
Shares Outstanding, K 28,998
Float, K 25,025
% Float 86.30%
Short Interest, K 2,680
Short Float 9.24%
Days to Cover 10.36
Short Volume Ratio 0.69
% of Insider Shareholders 13.70%
% of Institutional Shareholders 86.29%

Financials:

Annual Sales, $ 290,520 K
Annual Net Income, $ 89,160 K
Last Quarter Sales, $ 97,800 K
Last Quarter Net Income, $ 79,370 K
EBIT, $ 158,240 K
EBITDA, $ 164,950 K

Growth:

1-Year Return 85.19%
3-Year Return 226.30%
5-Year Return 294.28%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 455.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.66 on 11/03/25
Next Earnings Date 02/18/26
Earnings Per Share ttm 6.67
EPS Growth vs. Prev Qtr 106.20%
EPS Growth vs. Prev Year 192.31%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 42.28
Price/Earnings forward 33.59
Price/Earnings to Growth N/A
Return-on-Equity % 19.36%
Return-on-Assets % 17.65%
Profit Margin % 30.69%
Debt/Equity 0.00
Price/Sales 21.99
Price/Cash Flow 61.47
Price/Book 7.26
Book Value/Share 39.24
Interest Coverage -1.63
60-Month Beta 0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar